Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Net Equity Issued and Repurchased (2014 - 2026)

Stereotaxis (STXS) posted quarterly Net Equity Issued and Repurchased of $4.9 million for Q1 2026, up 15065.62% year-over-year from N/an in Q1 2025, and down 38.15% quarter-over-quarter from $7.8 million in Q4 2025.

Stereotaxis (STXS) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Net Equity Issued and Repurchased for 13 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased rose 15065.62% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $20.5 million (up 6748.49% YoY), while the FY2025 annual figure was $15.7 million, up 5171.38% from the prior year.
  • Net Equity Issued and Repurchased fell to $4.9 million in Q1 2026 per STXS's latest filing, from $7.8 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $7.8 million in Q4 2025 and bottomed at -$26000.0 in Q2 2023.
  • Historically, Net Equity Issued and Repurchased has averaged $1.2 million across 5 years, with a median of $54000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased slumped 145.61% — and 2026, when it jumped 15065.62%.
  • Stereotaxis' Net Equity Issued and Repurchased stood at $61000.0 in 2022, then plunged by 57.38% to $26000.0 in 2023, then jumped by 511.54% to $159000.0 in 2024, then jumped by 4835.22% to $7.8 million in 2025, then plunged by 38.15% to $4.9 million in 2026.
  • Business Quant data shows STXS's Net Equity Issued and Repurchased at $4.9 million in Q1 2026, $7.8 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 29.31 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn 4.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.85 Mn
Mar 31, 2026 4.85 Mn
Dec 31, 2025 7.85 Mn
Dec 31, 2025 7.85 Mn
Sep 30, 2025 7.74 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 34,000.00
Jun 30, 2025 34,000.00
Mar 31, 2025 32,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 159,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 80,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 28,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 30,000.00
Mar 31, 2024 30,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00